Skip to main content
SpringerLink
Log in

Calcium acetate does not appear to increase the risk of cardiovascular calcinosis over sevelamer

  • Media release
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Fresenius Medical Care AG.Fresenius Medical Care Announces Positive Results from PhosLo CARE-2 Study. Media Release: 21 Nov 2006. Available from: URL: http://www.fmc-ag.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Calcium acetate does not appear to increase the risk of cardiovascular calcinosis over sevelamer. React. Wkly. 1130, 4 (2006). https://doi.org/10.2165/00128415-200611300-00008

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200611300-00008

Keywords

Search

Navigation